Profound Medical annual gross margin
2019
2020
2021
2022
2023
2024
2025
Profound Medical's gross margin was 70.77% for fiscal 2025.
View full Profound Medical company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 70.77% | −1.48 pp |
| 2024 | 2024-12-31 | 72.25% | −0.85 pp |
| 2023 | 2023-12-31 | 73.10% | +27.88 pp |
| 2022 | 2022-12-31 | 45.22% | +2.27 pp |
| 2021 | 2021-12-31 | 42.95% | −4.61 pp |
| 2020 | 2020-12-31 | 47.56% | −9.70 pp |
| 2019 | 2019-12-31 | 57.26% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 78.41% | −3.26 pp |
| Q1 2026 | 2026-03-31 | 71.80% | −7.35 pp |
| Q4 2025 | 2025-12-31 | 59.42% | −14.16 pp |
| Q3 2025 | 2025-09-30 | 77.70% | +7.36 pp |
| Q2 2025 | 2025-06-30 | 81.68% | +8.92 pp |
| Q1 2025 | 2025-03-31 | 79.15% | +8.11 pp |
| Q4 2024 | 2024-12-31 | 73.57% | — |
| Q3 2024 | 2024-09-30 | 70.34% | — |
| Q2 2024 | 2024-06-30 | 72.76% | — |
| Q1 2024 | 2024-03-31 | 71.04% | — |
Over the last five reported fiscal years, Profound Medical's gross margin increased from 47.56% to 70.77%, a change of +23.21 percentage points. The latest reported quarter, Q2 2026, shows 78.41%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Profound Medical filings at SEC.gov ↗